A Study of the Efficacy of RWJ-333369 in the Prevention of Migraine

Completed · Phase 2

Conditions studied: Migraine Headaches

In brief

The purpose of this study is to evaluate whether RWJ-333369 is a safe and effective treatment in reducing the number of migraine headaches when added to a person's usual medications for acute migraine headache relief.

Key facts

Study ID
NCT00109083
Run by
SK Life Science, Inc.
People needed
300
Starts
2002-03-01
Expected to finish
2006-02-01
Last updated by the study team
2012-08-02

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.